Awards & Accolades

Awards & AccoladesHTDS Wins 2nd Place

Hard to Treat Diseases Inc. (HTDS.PK) Slavica Bio Chem Research Group wins the second place at the "Best technological innovation 2009" contest

Medal of Nikola Tesla

IBISS group, research team from Slavica Biochem, received a pres­tigious reward The first place and golden medal of Nikola Tesla for the year 2005, at the International Festival of Innovations, Know-how and Creativity held in Serbia.

Company News

  • Hard to Treat Diseases (HTDS) Melem Secrets' Completes Merger - BEIJING, CHINA, Feb. 25 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) - Further to the previously announced cosmetics merger (press release Feb 5, 2010) negotiations with the cosmetic company Melem Secrets, and other business matters the company is pleased to report that it has completed a cosmetic micro-conglomerate merger.

    Read Full Report Here

  •  

  • Chile Buys 2 Million Doses of Swine-Flu Vaccine SANTIAGO – The Chilean government has purchased 2 million doses of the vaccine against the AH1N1 flu virus for the immunization campaign that begins in the second half of March, the Health Ministry said.

    Read Full Report Here

  •  

  • A "Holy Grail" Of Healing. A new generation of researchers is changing the way we heal, one cell at a time. This is the second in a CBS News series on the innovative field of regenerative medicine.

    Read Full Report Here

  •  

  • Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production as a potential treatment of MS.

    Read Full Report Here

  •  

  • A Canadian study has found a drug that has been in use for 20 years, may also be an effective cancer killer.

    Watch Video Here

  •  

  • Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin.

    Download Update Here

  •  

Find out the latest information about our company at our Pink Sheets Profile.